Cell transfer component for multi-well assay device
Patent Information
- Application Number
- PCT/US2024/023594
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-04-06
- Filing Date
- 2024-04-08
- Publication Date
- 2024-11-28
AI Technical Summary
Current single-cell analysis techniques fail to effectively correlate the functional state of individual cells with their molecular constitution, particularly in heterogeneous cell populations, making it difficult to understand cellular responses to stimuli and perturbations at high throughput.
The development of encoded micro-components (EMCs) and a cell transfer component that allows for the precise association of individual cells with assay wells, using detectable codes and cell capturing elements to identify and transfer single cells from a heterogeneous population, enabling the correlation of cellular responses with specific cells and perturbations.
This approach enables the identification and analysis of individual cells within a heterogeneous population, facilitating the understanding of cellular responses to stimuli and perturbations, thereby improving the stratification of cell types and enhancing the understanding of biological processes and disease states.
Smart Images

Figure US2024023594_28112024_PF_FP_ABST
Abstract
Description
Attorney Docket No.009775.00019\WO CELL TRANSFER COMPONENT FOR MULTI-WELL ASSAY DEVICE Technical Field
[0001] This disclosure relates to devices that facilitate high throughput assays and more particularly to encoded micro-components configured to specifically associate individual wells with the contents of the individual well. The present disclosure provides devices and methods for transferring single cells via a transfer component into an assay well. Also described herein may be a system configured to facilitate the identification of a specific cell from a population of cells, such as a population of heterogeneous cells, where a single cell from the population of heterogeneous cells may be subject to testing in a single assay well. Description of the Related Art
[0002] Despite research and technology advances in single-cell analysis, there continues to be a gap in knowledge between attributing functional cellular data and molecular cellular data to cells subject to a stimulus or a perturbation at very high throughput. Conventional single-cell analysis may provide information on the genetic profiles of an analyzed cell and / or a limited proteomic profile, but such analyses fail to include information regarding the functional state of the cell. Relating the functional characteristics of individual cells to their underlying molecular constitution may be incredibly valuable for understanding, modeling, and engineering certain areas of biology. In addition, the ability to evaluate different cells originating from a population of cells, such as a heterogeneous population of cells, and subject to the same stimulus or perturbation may provide a useful stratification that may elucidate how different cell types express individual functionality. In this way, functionality may translate differentials of cells into specific classes of cells (specific cancer cells, neurons, epithelial cells, adipose cells, and the like). Thus, the capability to relate a single cell with at least one aspect of functionality is of exceptional importance.
[0003] Due to the diversity of cells tested and the difficulty correlating spatially defined functional assays to pooled sequencing readouts on current versions of sequencers, techniques and technology that can associate molecular and functional states of a cell arising from a heterogeneous population of cells are lacking. Further, there is a need to correlate a cellular response in a given assay well to the identity of the cell in that well and / or to a perturbation that accompanied that cellular response. Notably, changes in functionality and / or features of two different cells, originating from a heterogeneous population of cells, due to the two different cells individually being exposed to a same stimuli or perturbation may differ.
[0004] Human tissues are comprised of a highly heterogeneous mixture of cells interacting and regulating each other. As such, there is a need to comprehensively understandAttorney Docket No.009775.00019\WO individual cells, their molecular signatures, and their environment as a basis to assess the modulation of their functionality in the development of novel pharmaceutical compounds. In addition, cellular function is the foundational cornerstone in the understanding of the precise biology of disease states which, in turn, provides for a reasoned approach to treating the disease.
[0005] High-throughput single-cell multi-omics have been bolstered by innovations in a myriad of differing technologies. Many assays have been developed for ascertaining high quality data about the genomic profile of individual cells. Knowing the genomic sequence of a cell alone, however, often fails to provide adequate cellular information to elucidate the functional relevance of gene products produced by either an individual cell and / or interaction between different cells within a complex living system.
[0006] Despite progress in the field, there remains a gap in knowledge as to the change in functionality and / or one or more features of individual cells in response to a stimulus. And further, there is a lack of understanding regarding how the change in functionality and / or one or more features initiates or continues a cascade of biological events within a complex living system. Absent knowledge of the change in functionality and / or one or more features in response to a given stimulus, the relevance of such a change is not likely to be illuminated. At a basic level, there is an ongoing need for an understanding of how to correlate a change in functionality and / or one or more features of a specific cell subject to a given stimulus to the cascade of biological events flowing therefrom. Summary
[0007] The present disclosure provides encoded micro-components (EMCs) configured to associate the identity of a living cell within a multi-well assay with a particular well, where each well in the multi-well assay holds a single unique cell originating from a heterogenous population of cells.
[0008] Provided herein are transfer components for use with a multi-well assay device and methods of using such transfer components. The transfer component may be a stand-alone device affixed to, and / or a component of (e.g., integral with) a multi-well assay device, which may employ at least one EMC. Accordingly, the present disclosure provides a transfer component configured to transfer a single viable cell to a single well of the multi-well assay device, the transfer component comprising: an enclosure having a base and / or bottom portion, the bottom portion including a floor with side walls extending upward; at least one inlet port positioned in at least one side wall and at least one outlet port positioned in at least one side wallAttorney Docket No.009775.00019\WO a vacuum port; and a transfer surface (e.g., tray), wherein the transfer surface comprises at least one cell capturing element, and wherein the transfer surface is configured to engage with the enclosure such that the transfer surface is positioned between the floor of the bottom portion of the device and the top of side walls so as to form a sealed compartment (e.g., flow cell) below the transfer surface and an open volume above transfer surface.
[0009] In some embodiments, the transfer component may include a top portion having side walls that may be configured to engage with the side walls of the bottom portion to form a sealed cell transfer device. In some embodiments, the top portion and the bottom portion are integral with each other. In addition, in an exemplary embodiment, the transfer surface of the transfer component may include at least one cell capturing element that may comprise at least one adhesion site (e.g., cell adhesion site). Each of the at least one cell capturing element may comprise at least four adhesion sites, allowing for at least four points of contact with a single cell to the at least four adhesion sites of the capturing element. The adhesion site(s) may be, for example, a number of hole(s) (e.g., a number of through holes through the transfer surface) in a pattern / distribution and having a size and / or shape (e.g., having one or more diameters and / or areas) such that the adhesion sites are configured to contact the cell surface over an area such that when a vacuum (negative pressure) is applied across the hole(s), the cell may stably adhere to all or part of the pattern of holes. The adhesion sites may also, or alternatively, comprise wells having diameters and depths similar to a diameter of a single cell (e.g., 0.5-2x the diameter of a single cell in diameter and approximately 0.5-2x the diameter of a single cell deep). The cell transfer component may be configured to cause a flow of cells in media over the adhesion sites, such that single cells adhere to single adhesion sites either by vacuum force or by gravity allowing the single cell to settle into a single well. Further, the transfer component and the assay device may interlock such that the adhesion sites of the at least one cell capturing element (e.g., a plurality of cell capturing elements) align with the assay wells of the assay device. In some embodiments, the transfer component is integral with the assay device as a single assay device in which the capturing elements in the transfer surface of the transfer component are aligned with and face corresponding assay wells of the assay device (e.g., aligned with centers of corresponding assay wells in a one-to-one relationship). the assay wells may be arbitrarily sized. For example, the assay wells may have a diameter that is at least 2x that of the adhesion site(s) / wells as adhesion sites.
[0010] Provided herein is an assay device comprising a plurality of assay wells such that each assay well accommodates at least one unique viable cell, wherein the unique viable cell arises from a population of heterogenous cells and wherein each assay well includes at least oneAttorney Docket No.009775.00019\WO encoded micro-component (EMC), the EMC comprising: a detectible code on at least one surface of the EMC, the detectible code including an identifiable pattern of at least one label and / or image, wherein the detectible code on the EMC is unique to the assay well and the detectible code links the identity of the unique viable cell to the assay well from which the unique viable cell originated.
[0011] The disclosure also provides for a system that may facilitate the identification of a specific cell from a population of heterogeneous cells, where a single cell from the population of heterogeneous cells may be subject to testing in a single assay well.
[0012] Accordingly, provided herein is a system for conducting an assay starting with a heterogenous population of cells, the system comprising: a) a cell transfer component configured to transfer a single unique cell originating from the composition of heterogenous population of viable cells to a single assay well, the cell transfer component including at least one cell capturing element; and b) an assay device comprising a multiplicity of assay wells, wherein at least one well in the assay device includes a single unique cell that is identifiable by a readable code, and wherein at least one well in the assay device comprises: an encoded micro-component configured to identify at least one characteristic of the contents of the well and / or at least one aspect of the assay conducted in the well.
[0013] In some aspects, in the assay device and / or the system, the plurality of assay wells may include, for example, microwells, nanowells, and / or picowells. The detectable EMC code may be capable of detection via a variety of means. In some aspects, the detectable EMC code may be visually detectible. The visually detectable EMC code may, for example, be ascertained using a microscope. In some aspects, the detectable EMC code may be mechanically (e.g., physically / optically) detectible, for example, the detectable EMC code may be mechanically detectible by means including but not limited to fluorescence intensity. In still other aspects, the detectable EMC code may be chemically detectable, such chemically detectable means may include, among other suitable means, deoxyribonucleic acid (DNA) sequencing (see, e.g., U.S. Patent Application No. 17 / 687,376 filed on March 4, 2022 to Lance et al., incorporated by reference herein in its entirety). Alternatively, or in addition, the detectable EMC code may include at least one detectable dot (e.g., light-emitting / electromagnetically detectable dot / chip) and / or detectable color (e.g., a dye). One example of a detectable dot may be a quantum dot. In some aspects, each detectable dot may be detected by the same means of detection. For example, each detectable dot may be discerned using visual means, chemical means, biochemical means, mechanical means, or spectroscopic means. Alternatively, or in addition,Attorney Docket No.009775.00019\WO each detectable dot may be discerned using one or more detection means (e.g., a combination of different detection means). A non-limiting example may be that each detectable dot may be discerned using a combination of both visual and chemical means.
[0014] In some embodiments, in the assay device and / or the system, the EMC may include an orientation marker. The orientation marker may be included within the detectable EMC code located on at least one surface of the EMC. In some aspects, the orientation marker may be a unique label and / or image that may be used, for example, to properly orient the reading of the detectable EMC code.
[0015] In some embodiments described herein, the EMC provided in each assay well may include three or more surfaces. For example, in such aspects, the identical detectible EMC code may be included on more than one surface of the EMC.
[0016] In an exemplary embodiment, the EMC may be implanted into a bead such that at least one surface of the EMC is exposed on the surface of the bead. For example, the at least one surface of the EMC that is exposed on the surface of the bead may include the detectable EMC code, and thus the detectable EMC code on the surface of the EMC may still be readable while embedded in the bead.
[0017] Further, the assay device and / or system described herein may allow for the identification of additional features of an assay, including but not limited to such features as the identity of the technician that conducted an assay, as well as assay conditions (i.e., temperature, pH, atmospheric pressure, concentration, etc.), date and / or time the assay was conducted, one or more (e.g., any / all) synthetic steps used to generate a test compound, and / or one or more (e.g., any resulting) reaction products of the assay.
[0018] In some aspects, the devices, methods, and systems provided herein may facilitate high throughput assay procedures. Such assay procedures may include but are not limited to eliciting cellular activity in response to a perturbing event. In some aspects, the devices, methods, and systems disclosed may include capturing, culturing, perturbing, and / or performing assays on single cells. For example, in some aspects, the devices, methods, and systems provided may facilitate a cellular assay. Further, the devices, methods, and systems may correlate information obtained from the cellular assay to an individual cell subjected to the assay, based on the assay well from which the cell originated. For example, captured genomic information (e.g. nucleic acid sequence) obtained from the cell may be correlated to functional and / or imaging analysis performed on the same cell during and / or after perturbation. Brief Description of the Drawings
[0019] The drawings described herein are for illustration purposes only and are notAttorney Docket No.009775.00019\WO intended to limit the scope of the present disclosure in any way.
[0020] FIGS. 1A to 1E are illustrations of exemplary EMC embodiments. FIG. 1A shows a circular EMC and FIG. 1B shows the same circular EMC from a different angle. FIG. 1C shows an EMC having the shape of a pyramid. FIG. 1D shows an EMC taking the shape of a multi-surface wedge-like object. FIG. 1E shows a hemisphere-shaped EMC. FIGS. 1F-1G show example EMCs fabricated by etching silicon discs;
[0021] FIGS. 2A and 2B are illustrations of exemplary assay wells. FIG. 2A shows a partial view of an assay well within an assay device in which an EMC is located. FIG. 2B shows an assay well in an assay device having a recessed portion such that the recessed portion is sized to hold the EMC but too small for a cell;
[0022] FIG. 3A shows a bead with at least one EMC embedded on the surface of the bead. As shown in FIG. 3, in addition to multiple copies of a releasable test compound (labeled here as “A”), the bead shows an EMC partially implanted within the bead and the detectable EMC code visible on the surface of a fully implanted EMC. FIGS. 3B-D show examples of EMCs embedded in / attached to beads;
[0023] FIG. 4A and 4B show an EMC configuration and EMC coding component. FIG. 4A shows an EMC configured by two distinct shapes joined together. FIG. 4B shows an EMC coding component employed to identify a reagent used to make a compound;
[0024] FIGS. 5A to 5C illustrate iterative examples of a cell capturing element. FIG. 5A shows a cell capturing element in a transfer surface of a transfer component configured to impart minimal stress on the cell during cell capturing. FIG. 5B shows a transfer surface of a transfer component having a cell capturing element located within a depressed region of a transfer component. The cell capturing element is configured to provide more surface contact between the cell and the capturing element thereby reducing stress on the cell during cell capturing. FIG. 5C shows a cell capturing element with at least four holes / adhesion sites and a cell that is adhered to the cell capturing element via a vacuum force sufficient to retain the cell in place;
[0025] FIG. 6 shows a schematic of a cell transfer component comprising a cell capturing element in the transfer surface within the transfer component that allows for capture of a single cell from a heterogenous population of cells.
[0026] FIG. 7 shows an example implementation of the transfer component as part of a multi-well assay device;
[0027] FIG. 8 shows another example implementation of a transfer component as part of a multi-well assay device;
[0028] FIG. 9 shows an example multi-well assay device comprising a transfer device;Attorney Docket No.009775.00019\WO
[0029] FIG. 10 shows a brightfield image of cells after being transferred via the example multi-well assay device comprising the transfer device. Detailed Description
[0030] Provided herein are encoded micro-components (EMC) configured to facilitate assay methods by assigning individual wells an EMC with a detectable code that is configured to identify at least one unique component (e.g., from a living and / or viable cell) that originated from an individual well within a population of wells. Also disclosed are transfer components and methods configured to transfer a single cell from a specific site in the transfer component into an individual corresponding assay well. Systems employing these components in an integrated approach are also disclosed herein. Definitions
[0031] Terms not defined herein have their accepted scientific and medical meaning.
[0032] The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting to the described embodiments. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise.
[0033] As used herein, the term “optional” or “optionally” means that the subsequently described event or circumstance can or cannot occur and that the description includes instances where the event or circumstance occurs and instances where it does not occur.
[0034] As used herein, the term “about” when used before a numerical designation, e.g., temperature, time, amount, concentration, and such other, including a range, indicates approximations that may vary by ( + ) or ( - ) 10%, 5%, 1%, or any subrange or sub-value there between. Preferably, the term “about” when used with regard to a dose amount means that the dose may vary by + / - 5%.
[0035] As used herein, the term “comprising” or “comprises” is intended to mean that the compositions and methods include the recited elements, but not excluding others.
[0036] As used herein, the term “consisting essentially of” when used to define compositions and methods, shall mean excluding other elements of any essential significance to the combination for the stated purpose. Thus, a composition consisting essentially of the elements as defined herein would not exclude other materials or steps that do not materially affect the basic and novel characteristic(s) of the claimed invention.
[0037] As used herein, the term “consisting of” shall mean excluding more than trace elements of other ingredients and substantial method steps. Embodiments defined by each of these transition terms are within the scope of this invention.Attorney Docket No.009775.00019\WO
[0038] The term “encoded” refers to a code comprising one or more labels and / or images that are found on one or more surfaces of a micro-component.
[0039] The terms “encoded micro-component” also referred to as “EMC” and / or “EMS device” may relate to an encoded object having any shape, such as a sphere, a cube, a cylinder, or any other shape. In some aspects, the shape may have any shape that includes a surface and / or at least 2 surfaces / faces that point in multiple directions. For example, the shape may be a hemisphere having a flat surface and / or a curved surface, and, preferably, at least 3 surfaces / faces that are pointed in multiple directions. In addition, an EMC may be a structure having more than 3 surfaces / faces, for example, the EMC may take the shape of a pyramid, a pentagonal shape, or any other suitable shape having more than 3 surfaces / faces. In certain instances, an EMC may be embedded in and / or attached to a bead. An EMC may, for example, be attached to a bead via magnetic forces. In all cases, at least one surface of the EMC is encoded with a detectable code. For example, a hemisphere EMC may be encoded with a detectable code on its flat surface and / or curved surface. The definition is not so limited, however, as in some aspects, a plurality of EMC surfaces / faces may be encoded with the same detectable code (e.g., such that the detectable code is detectable from various perspectives / for various orientations of the EMC). In other aspects, the different surfaces / faces of the EMC may be encoded with different detectable codes. Additionally, an EMC may include 2 or more codes located on at least one surface of the EMC.
[0040] The terms “detectable EMC code”, “detectable code”, “discernable code”, and / or “readable code” may refer to a code present on at least one surface of an EMC. Further, more than one surface of an EMC may include the same detectable EMC code.
[0041] Alternatively, or in addition, a different detectable EMC code may be present on different (e.g., each) surface of the EMC. A detectable EMC code is capable of relaying to the user a single or multiple pieces of information for a given well comprising the detectable EMC code and / or a bead comprising the detectable EMC code. In some embodiments, the code may be initiated with a specific prefix unique to (e.g., indicating) the technician conducting the assay, the remainder of the code providing one or more pieces of additional information. For example, in addition, or alternative, to providing the identity of the technician that conducted the assay, an EMC having a single EMC code or multiple detectable EMC codes may also encode for such information as the date and / or time the assay was conducted, the conditions of a particular assay, and / or any other relevant information having to do with an assay performed on living or viable cells. For example, a second or subsequent code present on one or more surfaces / faces of the EMC may indicate particular assay conditions and thus may indicate the presence of a particular chemical compound, cytokines, or immune cells in the well containingAttorney Docket No.009775.00019\WO the EMC. A detectable EMC code may be a collection of patterns and / or labels. The definition is not so limited, however, as a detectable EMC code may include symbols, characters, shapes, colors, quantum dots, fluorescent tags, or any other discernable medium. A detectable EMC code may comprise one type of code, e.g. include only a series or number of shapes, or a combination of different code types, e.g. shapes, colors, quantum dots, fluorescent tags, etc.
[0042] The terms “discernable”, “detectable” and / or “readable”, as they relate to a discernable code refer to a code that is visibly, chemically, or spectroscopically readable. So, for example, a visibly discernable code includes one that may read with magnification such as a microscope. A chemically discernable code may include DNA and / or ribonucleic acid (RNA) that is bound to the micro-component, provided that where the code contains two or more labels or images, each label or image is a separate, unique strand of DNA. A spectroscopically readable code refers to separate labels which may include, for example, fluorescent labels distinct from each other on the micro-component. In some embodiments, the discernable code can use a mixture of such readable components. For example, the orientation marker in the code may be fluorescent and the remainder of the code may be visibly readable.
[0043] The term “code” includes any set of images, numbers, lines, and / or any combination thereof, where at least one of the images is not based on a nucleic acid. Images include structural images such as pictures, drawings, colors, quantum dots, Morse code, Roman numerals, or other visual patterns recognized by a reader of the code (e.g., a detector / interpreter of the code). Lines may include, but are not limited to, computer-readable barcodes or any other computer-readable codes.
[0044] The term “orientation marker” is defined as a component in the detectable EMC code that instructs the user where to start reading the code. For example, a detectable EMC code can be etched through the EMC and as a result, the underside of the EMC will read differently from the top side of the EMC. In such cases, the detectable EMC code may contain a common feature or “orientation marker” as the starting point for the code. Non-limiting examples of such a feature and / or marker may include a capital C, a dollar sign ($), a hashtag (#), and / or any other feature that is uniformly used to identify where to start reading the code. Although the orientation marker will typically be found at the start of the detectable EMC code, the orientation marker can also be inserted at a point intermediate in the code, to be used, for example, as a security measure whereby only certain individuals are able to read the code. In addition, the orientation marker associated with the code may be an image or label selected from a group of unique images and / or labels that are used either alone or in combination to identify the start of the code. For example, a single $ by itself may not indicate the starting point of the code but two $$ may serve as the orientation marker. The different types of orientationAttorney Docket No.009775.00019\WO markers are endless. Other examples of such orientation markers that may define the starting point for the detectable EMC code may include the dollar sign adjacent to a particular number such as $7 or a combination of numbers such as 77$. The orientation marker may be further protected by allowing for intervening “nonsense” labels or images. In such a case, the orientation marker may direct the reader to a first code such as “$!” from which the technician is instructed (separately) to a series of non-sense images and / or labels such as the next occurrence of “Z”. When a specific non-sense image is reached, for example, the technician may read and decode the code following the non-sense symbol. Whatever the form the orientation marker takes, the critical feature of the orientation marker is that it is orientable (asymmetrical in at least one direction) and has a known orientation (e.g., is known and can be used to orient the code of the EMC).
[0045] The term “micro” in “micro-component” refers to any structure having its longest axis which is less than 1,000 microns (i.e., a micron and / or sub-micron structure). The term “micro-component” refers to a micron and / or sub-micron materials that are structured, inert, retrievable in an aqueous medium, and labeled with a discernable code on at least one of the micron and / or sub-micron structures. The exact size of the micro-component is dependent on the size of the micro-well. In one exemplary embodiment, the size of the micro-component occupies no more than 50% of the volume of the assay micro-well, preferably no more than 25% of the assay micro-well; and more preferably less than 10% of the volume of the assay micro-well. The shape of the micro-component is not critical and can include, by way of example only, cubical, cylindrical, and elliptical shapes.
[0046] In some embodiments, the encoded micro-component is generated as a discrete, stand-alone, structure. In another embodiment, the encoded micro-component is sized and shaped to be implanted into and / or attached to a bead used in the assay provided that the implantation retains an exposed surface with a discernable code. In such a case, multiple encoded micro-components with the same discernable code can be implanted into the bead to ensure that at least one of the implanted components retains a discernable code.
[0047] The term “assay bead” or “bead” refers to a bead that may comprise a compound releasable from the bead when placed in a well. The bead may allow for the change in functionality and / or one or more features of a cell to be measured either alone or in the presence of additional components in the well. Such additional components may include antibodies, cytokines, chemokines, and the like. In addition, in some aspects, the assay beads may typically include an encoded structure such as DNA that correlates to and / or codes for the compound released from the bead. Additional features for such beads are well known in the art including an RNA-capturing element incorporated thereon.Attorney Docket No.009775.00019\WO
[0048] The term “perturbation” refers to a disturbance or interruption to a system or process that may cause it to deviate from its normal state or path of development. A “perturbation” may refer to a physical, chemical, or biological change that affects the functioning of a system, such as a change in temperature, osmolality, pH, the removal of a compound or feature (e.g., removal of a single nutrient), or the introduction of a new species (e.g., chemical species). Cell perturbation may be employed to measure and / or analyze the effects of altering the normal functioning of cells. As such, perturbation may be facilitated by introducing a foreign substance into the cell, such as a drug, hormone, or genetic material, that disrupts the normal functioning of the cell. The effects of the perturbation can then be measured and analyzed to gain insight into the role of the perturbed gene or protein in the cell’s normal functioning. Insight gleaned from perturbing a cell may be used to investigate the mechanisms of disease and drug development, as well as to identify new targets for drug development.
[0049] The term “stimulation” refers to the process of applying external stimulus to a cell and / or cell culture in order to induce or enhance a physiological response. For example, cell stimulation may involve the release of hormones, neurotransmitters, and / or other molecules that cause a change in the cell’s activity which in turn may alter gene expression, protein production, cell cycle progression, and other cellular processes. Cell stimulation may damage a cell by causing changes in the cells’ structure, metabolism, or physiology. Further, stimulation of a cell may lead to cell death, either directly or indirectly, by activating certain pathways or proteins that induce cellular damage. Damage can also be caused by overstimulation, which can lead to an increase in intracellular calcium, oxidative stress, and cell death. Additionally, certain chemicals used in the stimulation process can directly damage a cell’s membrane, leading to lipid peroxidation, membrane disruption, and cell death.
[0050] Generally, cell stimulation involves the addition of an external agent, such as a growth factor or an agonist, to the cell environment. Cell perturbation, on the other hand, is typically an experimental technique used to alter or disrupt a cell’s natural processes. Cell perturbation may be used to investigate the effects of a compound or other external agent on the cell’s behavior. Unlike cell stimulation, cell perturbation usually does not involve the addition of an external agent, but instead involves disrupting the cell’s environment in some way, such as through temperature and / or pressure changes. An intended cell perturbation at one level may be desired whereas extending the perturbation to a different level may be undesired. In such cases, undesired perturbations are to be avoided as such undesired perturbations may result in inaccurate, confounded, or unusable experimental results.
[0051] The term “split pool split generation” may refer to a technique used to generate test compounds in a systematic way. Split pool split generation involves breaking down a largerAttorney Docket No.009775.00019\WO pool of compounds into smaller pools, and then combining these smaller pools into new random combinations. This process is performed multiple times, resulting in a large number of unique test compounds. In some examples, a test compound may be generated by a single precursor molecule. The precursor may be split into two parts, the “split pool” and the “split product”. The split pool is further reacted with reagents to yield a range of possible reactions and products. The split product is then used to synthesize the desired test compound. This technique may be useful for creating a library of compounds from a single precursor molecule, making it an efficient method for drug discovery. Additionally, split pool split generation may allow for the efficient testing of a large number of compounds in a shorter period of time and using fewer resources.
[0052] In some embodiments, the EMC may comprise one part of a multi-variate device having multiple functionalities (see FIG. 4A). For example, the EMC may include two separate portions where one portion of the multi-variate device may have a surface comprising a reactive functionality that allows for the generation of a releasable test compound and a different part of the EMC may comprise a recordation portion. Still further, a different portion of the same EMC may detect changes in reaction conditions such as pH, or temperature. For example, a reactive functionality may be triggered by a specific stimulus. Non-limiting examples of a stimulus that may trigger the reactive functionality of an EMC may include physical, biochemical, and / or genetic stimuli. Further, a detectable code may be added to and / or generated onto the EMC for each step in the synthesis of the compound, for example, in a split-pool-split generation of the test compound. In some aspects, the EMC may have a T-shape that may use two different surfaces (FIG. 4A). The T-shaped EMC may have one surface capable of compound synthesis and another surface that may identify the synthetic steps that were employed to create the compound. In addition, during the split-pool-split procedure, in each split step involved in the synthesis of a compound, the EMCs that were split into a separate pool may be isolated and a colored magnetic particle or particles may be added to the pool. In some aspects, the specific color of the magnetic particle may indicate the specific step in the reaction sequence and the particle may be coated with a unique identifier such as a unique fluorescent molecule having a characteristic fluorescent peak to indicate the specific reagent used. Based on the combination of a unique color and a unique identifier of a particle, the technician may deconvolute a particular step used in the synthesis of the compound and also identify the particular reagent used.
[0053] The term “population of cells” refers to a plurality of cells, which may be of and / or derived from any immortalized cell line and / or any primary cells. A “heterogeneous population of cells” refers to a mixture of cells from two or more cell lines, cells of two or more cell types,Attorney Docket No.009775.00019\WO of two or more distinct morphologies and / or functionalities, etc.
[0054] In some embodiments, the bead may be magnetic and the EMC may be ferromagnetic, and as such the EMC will attach to the bead via magnetic interaction. The EMC and bead may attach by other means, such as van der Waals attraction and the like. In some aspects, the bead may be made of a soft composition where one or more copies of the EMC may be embedded into the outer layer of the bead while exposing at least one surface of the EMC, such that the exposed surface of the EMC presents a discernable code. The EMC may be fully embedded if the bead is transparent. Explanation of the Figures
[0055] The attached figures are meant to illustrate certain embodiments of the devices illustrated herein and are not to be interpreted as a limitation. Modifications and alterations are described herein and encompassed by the claims provided below as well as equivalents thereto.
[0056] Referring to FIGS. 1A-1E, these figures illustrate different embodiments of an EMC that may be placed into an assay well of an assay device. Such assay wells may be typically found in conventional high-throughput assay devices, are generally cylindrical in shape, and have a range of sizes, e.g. microwells, picowells, nanowells, etc. Other assay well shapes are contemplated, however, and the particular shape of the assay well is non-limiting. For ease of illustration, a cylindrical shaped assay well is depicted in FIGS. 2A and 2B.
[0057] FIG. 1A shows an EMC (100a) having a cylindrical shape with a first or top side (102a) and a second or bottom side (104a). The EMC (100a) shown in FIG. 1A also has a height (106a) between the bottom side (104a) and the top side (102a) and a width (108a). In the embodiment illustrated, a discernible and readable EMC code (110a) is located on the top side (102a) of EMC (100a). Alternatively, or in addition, as shown in FIG. 1A, the same EMC code (110a) may be located on both the top side (102a) and bottom side (104a) of the EMC (100a), such that the two sides of the EMC (100a) may be interchangeable. As a result, the identical EMC code (110a) will be face up regardless of whether the top side (102a) or the bottom side (104a) is exposed in the well of the assay device.
[0058] In FIG. 1B, the EMC (100b) has a similar cylindrical shape to the EMC (100a) in FIG.1A, however, a discernible and readable EMC code (110b) is instead located on the side (112b) of the EMC (100b). In this configuration, it is irrelevant which side, the top side (102b) or the bottom side (e.g., (104a) in FIG. 1A), faces down when placed into the well. The readable EMC code (110b) located on the side (112b) of the EMC (100b) eliminates the possibility that the only encoded surface of the EMC (100b) will orient with that surface facing the bottom of the assay well and / or another surface (e.g., a bead).
[0059] As shown in FIG. 1C, in some embodiments the EMC (100c) may be pyramidal inAttorney Docket No.009775.00019\WO shape thereby allowing for four sides or surfaces / faces. The advantages of a pyramidal-shaped EMC (100c) may be that, when added to an assay well, three of the four surfaces / faces of the pyramid may expose a discernable and readable EMC code (110c).
[0060] Referring to FIG. 1D, in some embodiments, an EMC (100d) may have a wedge- like form. Accordingly, FIG. 1D shows an EMC (100d) having one side of an otherwise cubic structure (114d) having a tapered edge (116d). The configuration shown in FIG. 1D may be used to partially embed the EMC (100d) into one or more beads. As previously mentioned, a bead impregnated with an EMC (100d) may also have the capability to deliver a candidate compound to a given well (see, e.g., FIG. 3). In the case of a translucent / transparent bead, the EMC (100d) can be entirely embedded. Of particular interest is the placement of the discernable and / or readable EMC code (110d). For example, the EMC (100d) configuration is shown in FIG. 1D may be embedded into a bead such that the EMC code (110d) as seen on a bottom or exposed surface (118d) of the EMC (100d) will allow for the EMC code (110d) to be read from the surface (118d) that protrudes from the bead.
[0061] FIG. 1E depicts an EMC (100e) having only two surfaces / faces. FIG. 1E shows a 3D semi-circle shaped EMC (100e). Such an EMC (100e) configuration may also be referred to as hemispherical in shape. The EMC (100e) has 2 surfaces / faces, a first flat surface (120) and a second round or curved surface (122e) forming a semi-sphere or hemisphere. The hemispherical EMC (100e) may, for example, include a code (110e) on the first flat surface (120e) as shown in FIG. 1E and / or on the round or curved surface (122e) (not shown). Alternatively, or in addition, a hemispherical EMC (100e) having a code (110e) positioned on the flat surface (120e), may be located on a flat surface (120e) down in an assay well such that the EMC code (110e) is detectable through the bottom of a clear assay well (see, e.g., FIG. 2A). Similarly, a code (110a- d) on a flat surface of another shaped EMC (e.g., 100a-100d) may be read through the bottom or other wall of a clear assay well and / or clear bead.
[0062] FIGS. 1F-1G show EMCs fabricated by etching silicon discs. To fabricate the EMCs in FIGS. 1F-1G, 10 or 15-micron silicon discs, respectively, were etched using nanofabrication techniques such that each EMC has a unique pattern. A photoresist layer was deposited on the top surface of a 100 mm diameter silicon-on-oxide wafer purchased from University Wafer (top Si layer 220 nm; middle oxide layer 3 micron; bottom Si layer 725 micron). A Heidelberg MLA150 direct write lithography tool was used to draft various 6 bit or 9 bit patterns within 10 micron or 15 micron diameter circles. Development, etching and liftoff using standard lithography processes resulted in 220 nm thick, 10-15 micron diameter silicon pucks of various patterns in 1- 10 million quantities that can be used as EMCs in the different embodiments of this disclosure.Attorney Docket No.009775.00019\WO
[0063] It is understood that where an EMC (100a-e) has two or more surfaces / faces such as those depicted in FIGs 1A-1E, the EMC code may be located on one, two, three, and / or all surfaces of the EMC (100a-e). Alternatively, or in addition, more than one EMC code (110a-e) may be placed on the EMC (100a-e). As discussed above, the EMC (100a-e) may contain multiple different EMC codes (110a-e). In some embodiments, for example, a first EMC code (110a-e) may include an orientation marker and / or that is specific for a first condition (e.g., cell type); a second EMC code (110a-e) may use a different orientation marker and / or be specific for a second condition (e.g., the identity of the assay operator); and a third EMC code (110a-e) may use an orientation marker that may be the same as and / or different from the first and second orientation markers and / or may identify the specific reaction conditions of the corresponding well, and so on. Also, or alternatively, the EMC code (110a-e) may comprise first, second, and third EMC codes.
[0064] FIGS. 2A-2B depict two assay well configurations. FIG. 2A illustrates an assay well (200a) having an opening (202a), and a floor (204a), with a two-surface hemisphere- shaped EMC (100e) device positioned on the floor (204a) of the well. The EMC as depicted in FIG. 2A also includes an orientation marker (210a). Although the orientation marker (210a) in the figure is represented as $$, it is noted that the orientation marker (210) may be any one or a collection of images and / or labels that may include but are not limited to, numbers, symbols, pictures, etc. Any EMC, such as EMCs (100a-100e), may be applied to an assay well(200a) and / or assay well device as disclosed herein and / or may be configured with an orientation marker (210a). FIG. 2B depicts an assay well (200b) with an opening (202b) and a floor (204b) and lacking the EMC (100e) device, for illustrative purposes / clarity only. As shown in FIG. 2B, the assay well (200b) may also, or alternatively, include a recess (206b), in the floor (204b) of the assay well (200b), that may be specifically shaped and sized to hold the EMC (100e) but not a cell (208b). In practice, the EMC (100a-e) may be designed to occupy minimal space in the assay well (200b), thereby not interfering with the cell (208b) or the assay being conducted while the EMC code is still readable. Alternatively, or in addition, the EMC (100a-b) may be situated in the recess (206b) of the assay well (200b) and a removable cover (not shown) may secure the EMC (100a-e) in place. Although not shown in FIG. 2B, other alternatives to secure the EMC in the recess (206b) of the assay well (200b) to ensure the EMC (100a-e) does not interfere with an assay may include snaps and / or protrusions positioned within a side wall of the recess (206b). As discussed above, there are a number of ways to ensure that an EMC (100a-e) in an assay well (200b) is positioned so that the discernable EMC code (110a-e) is readable.
[0065] Referring now to FIG. 3A, in some embodiments, one or more copies of the EMC (100d) device as shown in the wedge-like shape (see FIG. 1D), may be embedded in a beadAttorney Docket No.009775.00019\WO (300). As depicted in FIG. 3, the bead (300) may also be used to deliver a releasable test compound (302) (e.g., perturbation), labeled as “A” in the figure. As configured in FIG. 3, the EMC (100d) and bead (300) are combined into a single aggregate thereby limiting the amount of space occupied within the well (200a-b).
[0066] FIGS. 3B-D show examples of EMCs embedded in / attached to beads. FIG. 3B shows bright-field images of PEG-polyacrylamide hydrogel beads having attached silicon disc EMCs. The silicon disc EMCs were prepared similar to those in FIGS. 1F-1G. The silicon disc EMCs were embedded within PEG-polyacrylamide hydrogel beads prior to crosslinking inside a cylindrical microwell. The pre-polymerized mixture comprised 187.5mM AAm-PEG2K-NH3 and 62.5mM AAm-PEG3.7K-Aam and was crosslinked with 1%[v / v] 2-hydroxy-2- methylpropiophenone at appropriate UV dosage.
[0067] FIG. 3C shows beads randomly embedded with micro-components, such that the randomly embedded micro-components cause each bead to be unambiguously distinguishable from each other. In short, micro-components of polyethylene microspheres of different diameters (2 micron and 6 micron) were embedded within the pre-polymerization matrix described for FIG. 3B prior to crosslinking. The randomized patterns of the microspheres provide a high complexity optical code that uniquely identities each bead. Thus, the beads with micro-components so encoded can simultaneously serve as an EMC and for another purpose, such as a perturbation bead providing a test compound, as in FIG. 3A, as a capture bead, etc..
[0068] FIG. 3D shows beads with EMCs attached thereto and imaged in wells of a multi- well assay device. The EMCs were 40 micron diameter silicon discs coated with a thin layer of silicon oxide in a PECVD chamber. The silicon disc EMCs were incubated with 160 micron TENTAGEL®-amine beads. The silanol groups on the silicon disc EMC surface, generated by the silicon oxide coting, caused the silicon discs to electrostatically attach to the surface of the beads by charge interactions. FIG. 3D shows single beads visible in single wells, and the blow- up images show the EMCs attached to the beads, with visible and distinguishable codes.
[0069] In addition to being used as an identifier for a given cell (208b) deposited in a specific assay well (200a-b), the EMCs (e.g., EMCs (100a-e)) described herein may also be used to identify a compound structure. Such a compound structure may be identified by the EMC (e.g., EMC (100a-d)) instead of, in redundancy to, or in combination with conventional nucleic acids, e.g., deoxyribonucleic acid (DNA) and / or ribonucleic acid (RNA).
[0070] FIG. 4A shows an embodiment of an EMC (400a) having both a reactive portion (402a) and a recordation portion (404a). As seen in FIG. 4A, an EMC (400a) may include a portion that synthesizes a test compound--the reactive portion (402a)--as well as a portion configured to record the synthetic steps involved in the particular procedure and, accordingly,Attorney Docket No.009775.00019\WO the compound generated--the recordation portion (404a). In some aspects, a coded set of low micron (e.g., 100 microns or less, 50 microns or less, 10 microns or less, etc.) to sub-micron (less than 1 micron) particles having bound detectible labels may adhere to the recordation portion (404a). Simply for the sake of illustration, FIG. 4A depicts an EMC (400a) having the two portions (i.e., the reactive portion (402a) and the recordation portion (404a)) represented by different parts of the T-shaped EMC (400a) with the understanding that there may include a separate place to do the synthesis in the reactive portion (402a) and a separate portion configured to record each step involved the particular synthesis procedure and / or reaction in the recordation portion (404a).
[0071] Referring to FIG. 4B, an EMC (400b) may be employed in the generation of compounds. The EMC (400b) may be, for example, the same as the EMC (400a) in FIG. 4A. As such, FIG. 4B depicts how an EMC (400b) allows for the generation of test compounds with increased efficiency using a split-pool-split procedure. As shown in FIG. 4B, in the first step, commonly labeled EMCs (400b) are split into 5 groups (Pools 1-5). For demonstration purposes, only the recordation portion (404) of the EMC (400b) is shown and separate labels, A1, A2… A5, are employed in separate vessels to document the appropriate recordation portion (404b) of the EMC (400b). In the example shown in FIG. 4B, the label used is a micro- or sub- microbead (406b) with a common label that identifies the first step of the reaction sequence. Non-limiting examples of such labels may include different colors, different fluorescent molecules, different patterns of quantum dots, and / or any other suitable label. For example, the label on the micro- or sub-microbeads (406b) used in the first reaction vessels (A1-A5) may have a pattern of 3 quantum dots arranged to distinguish each reaction vessel from each other. Examples would include: horizontal line . .. Triangle . vertical lines | 1stvertical line with different shapes .__. . . | 2ndvertical line with different shapes .__ . |
[0072] The label on the beads (408b) used in the second reaction vessels (B1-B5) may have a pattern of 4 quantum dots arranged to distinguish each reaction vessel from each other. For the third, fourth, and fifth reactions, the label on the beads used in each of these may have 5, 6, and 7 quantum dots respectively. Alternatively, or in addition, the beads used in each of the 5 separate reaction steps may have a unique discernible color for each step. For example, the beads used in the first step may be red, the beads used in the second step may be blue, and soAttorney Docket No.009775.00019\WO on. In reality, there are an infinite number of possible labels that can be used on the beads including separate images and separate codes (e.g., 1001, 1002, 1003, 1004, 1005 for the first 5 reaction vessels; e.g., 2001, 2002, 2003, 2004, 2005 for the second 5 reaction vessels; and so forth).
[0073] In addition, each of these 5 labeled microbeads (406b) may be bound to a different detectable marker, 1, 2, 3, 4, and 5. In some aspects, the detectable marker may be a unique antibody (e.g. Ab-1 through Ab-5) or alternatively, the detectable marker may be a defined pattern of quantum dots that denote each separate reaction step. Other examples of detectable markers may include different fluorescent compounds or any other suitable form of detectable marker.
[0074] Still referring to FIG. 4B, the next step in the process may entail recording the synthetic conditions employed in the first reaction step of sub-pool 1 (Rx1). In some aspects, such synthetic conditions are recorded by attaching a microbead (406b) A1to the EMC (400b) as seen in FIG. 4B. Likewise, for Rx2, the EMC (400b) will acquire a label to denote Rx2 (A2), which similarly records the reaction steps. In the embodiment disclosed, the process is continued until Rx5 is reached.
[0075] Following the completion of the first step, all of the EMCs (400b) are combined or pooled and subsequently homogenized. As shown in FIG.4B, the EMCs (400b) are again split into 5 groups, B1, B2… B5, and 5 different reaction conditions and / or reagents may be used. Afterward, the first vessel may include 5 different compounds, all with 5 different A (A1-A5) substituents and 1 (one) B substituent (of B1-B5). The process is continued for 3 additional steps to provide for the following distribution of 3,125 different compounds in 5 vessels each containing 625 compounds where each the population of 5 compounds with unique E1-E5labels, 25 compounds with unique D1-D5labels, 125 compounds with unique C1-C5labels, 625 compounds with unique B1-B5labels and 3,125 compounds with unique A1-A5labels.
[0076] In the example shown in FIG. 4B, the last step in the process described herein may include homogenizing the compounds and thereby distributing the resulting beads into individual wells, preferably 1 bead per well. An assay may then be conducted and, following completion of the assay, any bead showing activity may be extracted from its well. The extracted bead may then be analyzed to determine the structure of the active compound.
[0077] In exemplary embodiments, the process of deconvoluting the structure on each bead is preferably done in the inverse of the reaction steps. For example, because Step E is the last reaction step, there are only 5 possible matches for the final step in the reaction.
[0078] Once that reaction step is ascertained, only 5 possible matches remain for the fourth step of the reaction. If the fourth step is coded by a fluorescent compound, for example,Attorney Docket No.009775.00019\WO then identification of that compound is made spectroscopically. The process is repeated until a determination of the reaction conducted in the first step (i.e., Step A in FIG. 4B) is completed.
[0079] The above approach allows beads to be split into 7 different sub-pools where 8 reaction steps may be employed. Consequently, the number of compounds that can be created and rapidly analyzed maybe 78 or over 5,000,000 separate and distinct compounds. The devices and methods described herein allow for the deconvolution of labels that may result in millions of separate compounds without the need for sequencing DNA or dealing with damaged DNA. In addition, since each step is individually marked and separately analyzed, the same labels may be employed in each of the separately marked beads used. Likewise, the EMC (400b) used can still be coded for the cell used in the assay well, thus establishing the versatility of this approach. Cell Transfer Component for transferring single cells to single wells of multi-well assay device
[0080] Also described herein is a high throughput assay device containing tens, hundreds, thousands, tens of thousands, hundreds of thousands, or millions of wells. Each well may be configured to include one or more EMCs along with at least one cell originating from a population of cells of interest, such as a substantially heterogeneous population of cells. To avoid having two different cells in a single well, a cell transfer component with the capability of transferring a single cell into a single well is required. The cell transfer component is configured to maintain cell viability and avoid cell damage during cell capture and transfer to a well of the multi-well assay device. Single-cell transfer components may therefore be configured to accommodate an aqueous solution, optionally comprising cell nutrients, throughout cell capture and transfer. In addition, because cells are substantially more fragile than most beads, cell transfer is best conducted under conditions that minimize undesired stimulus, such as excessive sheer or stress during capture and / or transfer, to avoid damaging, killing, or unintentionally stimulating changes in cells.
[0081] Accordingly, FIGS. 5A to 5C depict a portion of a cell transfer component that is configured to capture only a single cell. As seen in FIG. 5A, the portion of the single-cell transfer component (500a) includes at least one cell capturing element (502a), each of which may be aligned to and / or positioned to be aligned to a single well in an assay device (see, e.g., FIGS. 6-8). In particular, each cell capturing element (502a) may be positioned to face and be aligned opposite to the center of an opening of a single corresponding assay well in an assay device comprising and / or affixed to the cell transfer component. In addition to being properly aligned, the cell capturing element (502a) is configured to capture a single cell in a manner that reduces or eliminates unintended stress on the cell (504a) (shown in FIG. 5C). It is understood that the purpose of most cellular assays will be to perturb or stimulate the cell and subsequentlyAttorney Docket No.009775.00019\WO evaluate the impact of the perturbation or stimulation on the cell (504c, shown in FIG. 5C, not shown in FIGS. 5A-5B for clarity of illustrating other structures / features). For example, a change in functionality and / or one or more features of the cell caused by the perturbation and / or stimulation may be analyzed. In some cases, the perturbation may be induced by exposing a cell (504c) to be assayed (“assay cell”) to another type of cell (e.g., an immune cell) or exposing the assay cell to an antibody, a bacterium, a virus, a test compound, a physical perturbation, and / or any other suitable means of perturbation. In each case, the perturbation is conducted under controlled conditions, and therefore constitutes an “intended perturbation.”
[0082] Unintended perturbations may arise when a cell capturing element (e.g., cell capturing element (502a)) imparts substantial unintended stress on the cell. In such cases, the cell will become perturbed by the capturing process, and that perturbation may interfere with the accuracy of the experiment results. For example, unintended perturbations may raise the question, did the change in cell function / morphology / expression / behavior result from the test compound or the stress induced by the impact on the cell during the capturing process?
[0083] Previous single-cell capture devices employ capturing elements having one or two holes in each well of an assay device, but the wells of the assay device are necessarily approximately single-cell-sized to avoid capturing multiple cells in the well. Such capture devices do not allow for transferring each captured cell simultaneously to a single corresponding assay well of arbitrary / desired size. There remains a need for cell transfer devices and / or components that allow for transferring single cells into arbitrarily sized assay wells while reducing / avoiding stress to the cell during capture and transfer. Reducing / avoiding stress reduces / avoids unintended perturbations due to capturing the cell. The present transfer component comprises cell capturing elements that allow for transferring single captured cells to assay wells large enough to perform desired assays, such as proliferation assays, motility assays, etc.
[0084] As depicted in FIG. 5A, the cell capturing element (502a) provided comprises one or more holes / adhesion sites (506a) (e.g., one or more through holes through the transfer surface (508a) comprising the cell capturing element (502a)), each designed to form one or multiple points of contact with a cell. The one or multiple points of contact may amount to a total area of contact with the cell that is subject to a negative pressure applied to the one or more holes / adhesion sites (506a). The negative pressure applied over the total area of contact amounts to a total vacuum force sufficient to retain a cell at the cell capturing element (502a), for example, in the face of a flow applied over the cell and / or cell capturing element (502a). In addition, the size and / or area of the one or more holes / adhesion sites (506a) may be selected such that the resulting total vacuum force that is minimally perturbing / non-damaging to the cell. In anAttorney Docket No.009775.00019\WO exemplary embodiment, the number of holes / adhesion sites (506a) required to retain the cell is at least 2 or more, 3 or more, 4 or more, and preferably, at least 5 or more. In this exemplary embodiment, the holes may be sized such that a cell aligning over 2 or fewer holes / adhesion sites will likely suffer from a lack of sufficient contact points / area to stably remain on that cell capturing element (502a) without using potentially damaging vacuum pressure that may induce undesired perturbations in the cell (504a). In another exemplary embodiment, the number of holes / adhesion sites may be 1, and the hole / adhesion site may be sized such that an area of contact with the cell on the hole(s) is sufficient for a total vacuum force to be largely non- perturbing / non-damaging to avoid undesired perturbations. The hole / adhesion site is also small enough that the cell does not flow through the hole, if present, and / or to avoid a second cell from also adhering to the hole / adhesion site. For example, the hole diameter may be less than 1 / 3, less than 1 / 4, or less than 1 / 5 the diameter of a target cell and / or average cell of a population of cells. In some embodiments 5 micron holes may be used for cells that are 10 microns, or larger, in diameter.
[0085] The transfer component described herein includes a transfer surface comprising a cell capturing element (e.g., 502a) comprising one or more holes / adhesion sites (506a). In some embodiments, the cell capturing element (e.g., 502a) comprises multiple holes / adhesion sites (e.g., 4 or more) and consequently, includes a greater number of points of contact / adhesion with the cell. The underlying force required by each hole to stably retain the cell, therefore, is diminished as the number / size of holes / adhesion sites (506a) increases per cell capturing element (502a) (e.g., per area of the holes / adhesion sites (506a) per cell capturing element (502a)). Accordingly, in FIG. 5A, the cell capturing element (502a) is located on a portion of a top surface of a cell transfer surface (508a) of the cell transfer component. As shown in FIG. 5A, the cell capturing element (502a) includes a multiplicity of holes / adhesion sites (506a) that form the capturing element (502a). It is understood that the multiplicity of holes / adhesion sites (506a-c) depicted in Figures 5A-5C are illustrative only and not intended to be limiting. The number of holes / adhesion sites (506a) that make up a cell capturing element (502a) may range from 1 to about 4,000 and are sized and selected based on the size of the cells and the number of contact points / amount of contact area desired in light of a total vacuum force sufficient to overcome fluid flow forces (e.g., of an applied fluid flow over the transfer surface (508a)). In an exemplary embodiment, the number of holes / adhesion sites (506a) in each cell capturing element (502a) ranges from 4 to about 400, or from about 10 to about 100. If less than the sufficient force is applied, the cell can be displaced during normal loading of cells into the transfer component. For the purposes of this disclosure, the term “stably adhere” and similar terms refer to the fact that under the vacuum pressure applied, which is selected to reduce / avoidAttorney Docket No.009775.00019\WO perturbation in the captured cell, and the loading conditions used, cells that have insufficient contact points / area are subject to dislodgement from the cell capturing element (502a). In general, the vacuum to be applied is reduced such that the cell does not evidence a level of perturbation that adversely affects its value in the assay. The number of holes may be selected such that a size of each hole, for example, may be no more than about 5% of the surface area of the cell in contact with the hole and preferably no more than about 3% and even more preferably no more than about 1% of the surface area of the cell. Again, the rationale is that by employing a sufficient number of small holes / adhesion sites that contact the cell surface area, the stronger the adherence created while using less vacuum force. For example, in general, vacuum pressures may be about 0.7 atmospheres or less and, preferably, about 0.5 atmospheres or less.
[0086] FIG. 5B illustrates yet another embodiment of the cell capturing element (502b) within the cell transfer surface (508b) of the cell transfer component. As seen in FIG. 5B, the cell capturing element (502b) features holes / adhesion sites (506b) which are located throughout a scalloped and / or recessed region (510b) of the cell transfer surface (508b). The scalloped and / or recessed region (510b) may be recessed from the cell transfer surface (508b) by vertical walls, as shown, and / or scalloped / recessed by a gradual / sloped / bowl shape (e.g., that better conforms to the unstrained shape of a cell). The gradual / sloped / bowl shaped scalloped and / or recessed region (510b) is configured to increase the amount of cell surface that is in contact with the cell capturing element (502b) (e.g., by a recessed / scalloped shape better conforming to the unstrained shape of the cell than a strictly flat surface) such that even lower vacuum pressures can be used to stably adhere the cell to the capturing element (502b). In some embodiments, the scalloped and / or recessed region (510b) is approximately the same width and / or depth of a target cell to be captured and / or the average cell of a heterogeneous cell population. For example, the width / diameter of the scalloped and / or recessed region (510b) is, in some embodiments, 0.5-2x the width / diameter of a target cell and / or of an average cell of a heterogeneous population (e.g., an average width / diameter of the heterogeneous population). In some embodiments, 1-2x the width / diameter of a target cell and / or of an average cell. In some embodiments, the scalloped and / or recessed region (510b) has a depth (e.g., maximum depth) that is 0.5-2x the diameter (e.g., average diameter) of the target cell and / or the average cell. In some embodiment, the scalloped and / or recessed region (510b) has a depth of about 0.5-1.5x the height of cell (504c) at its maximum point and has a width / diameter no wider than about 1 to about 1.5 times the diameter of the target cell and / or the average cell. In some embodiments, the scalloped and / or recessed region (510b) is configured to be no deeper than about 1x the height of target cell and / or average cell, the diameter is about 1.1-1.3x the width / diameter of target cellAttorney Docket No.009775.00019\WO and / or average cell. In some embodiments, the scalloped and / or recessed regions (510b) can serve as cell capturing elements (502b) without any hole / vacuum / adhesion force -- cells can be flowed over the scalloped and / or recessed regions (510b) and allowed to settle into the scalloped and / or recessed regions (510b) without any applied vacuum and allowed to settle by gravity into individual scalloped and / or recessed regions (510b). The scalloped and / or recessed regions (510b) having a size similar to that of the target cells / cell population reduces the likelihood that more than one cell will settle into and / or be sucked into the scalloped and / or recessed region (510b). In this case, the transfer component comprising the transfer component (508b) does not require a bottom portion to provide differential flow across holes / adhesion sites (506b) and avoids any vacuum force on the cell (see, e.g., FIG. 8).
[0087] FIG. 5C illustrates an embodiment where a cell (504c) is captured by the cell- capturing element (502c). As shown in FIG. 5C, the scalloped and / or recessed region (510c) is configured to be no deeper, at its deepest point, than about 0.5-2x the height of cell (504c) and no wider than about 1-2x the width / diameter of cell (504c). In an embodiment, the depth of the scalloped and / or recessed region (510c) is about 0.5-1.5x the height of cell (504c), the width / diameter is about 1-1.5x the width / diameter of cell (504c). In an embodiment, the depth of the scalloped and / or recessed region (510c) is about 1x the height of cell (504c), the width / diameter is about 1.1-1.3x the width / diameter of cell (504c). Such depths and widths are configured to allow substantially a single cell (504c) to settle into the scalloped and / or recessed region (510b-c). As discussed herein, and shown in FIG. 8, the scalloped and / or recessed region (510c) may not comprise any holes when used as a cell capturing element (502c).
[0088] In some embodiments, where a heterogenous population of cells having varying heights, widths, and lengths is used, each of the measurements described above is adjusted to capture such a heterogeneous population of cells without causing multiple cells to populate a single cell capturing element (502c). Such adjustments are routine for the skilled artisan. Cell Transferring
[0089] Referring now to FIG. 6, a cell transfer component (600) comprises a bottom portion (602) and a top portion (604). In some aspects, the cell transfer component (600) may include a lid and / or cover (612) that may be positioned so that a sealed container is achieved. In some aspects, the lid and / or cover (612) may be a multi-well assay component, having a plurality of assay wells aligned with and / or configured to be aligned with cell capturing elements (502a-c) of the cell transfer component (600). In addition, side walls (616) of the lid and / or cover (612) may extend down to at least the top of side walls (614) extending upward from the bottom portion (602) of the transfer component to form a sealed cell capturing device (600). The side walls (614), may comprise a four sidewalls, with at least a first side wallAttorney Docket No.009775.00019\WO opposing a second side wall. Also, or alternatively, the lid and / or cover (612) may be integral with the top of the sidewalls (614). Further, the cell capturing device (600) depicted in FIG. 6 includes at least one inlet port (606) for fluid and an outlet port (607) for the fluid. In some aspects, more than one inlet port (606) may be used. A first inlet port (606) and first outlet port (607) (e.g., on the first side wall and the second side wall, respectively) facilitate the introduction of a flow of fluid over a transfer surface (e.g., tray) (508a-c), which allows for leakage / fluid transfer through cell capturing elements (502a-c). The first flow may be selected to cause cells to move across the transfer surface at a rate configured to populate the cell capturing elements. A second inlet port (606) and second outlet port (607) (e.g., on the first side wall and the second side wall, respectively) may also, or alternatively, facilitate the introduction of a second flow of fluid beneath the transfer surface (508a-c). The first flow and second flow may be selected to create a desired flow differential over the cell capturing elements (502a-c) that results in a negative pressure sufficient to capture a cell on the cell capturing element (502a-c). In some embodiments, for instance in Fig. 9, the first flow occurred at a rate of 5 microliters per minute, while the second flow occurred at a rate of 10 microliters per minute, setting up a pressure differential drawing cells and media across the cell capturing elements. The cell capturing device (600) includes at least one outlet port (607) and, in some aspects more than one outlet port (607). A cell transfer surface (e.g., a tray) (508a-c) positioned in the cell transfer component (600) may include a number of cell capturing elements (502a-c), only four of which are shown for illustrative purposes.
[0090] When used, the bottom portion (602) of the cell transferring component (600) optionally in combination with the top portion (604) is fitted to the inlet port (606) with a fluid delivery system (not shown) which initially contains cell culture media and / or a population of cells. When the fluid level reaches the inlet port (606) the fluid intake rate and the fluid outlet rate (e.g., via an outlet port (607)) are set to be equal, which will result in a constant fluid level. Also, or alternatively, the bottom portion (602) and the top portion (604) may be filled with the cell culture media. A first flow may be established in the bottom portion (602) and a second flow established in the top portion (604). Further, the fluid intake rate may then be adjusted slightly higher and a vacuum port (610) may be activated. The intake flow rate, the outlet flow rate, and the vacuum suction rate may be adjusted to be in equilibrium (the fluid level is maintained at a substantially constant level). The fluid delivered through the fluid inlet port (606) may thereby be adjusted to include a heterogeneous population of cells. For example, the heterogenous population of cells may include living, viable, human cells. As the cells are captured by the cell capturing elements (502) the vacuum pressure required to maintain equilibrium increases. The process is continued until the increase in pressure indicates thatAttorney Docket No.009775.00019\WO substantially all of the cell capturing elements contain a cell stably adherent thereto.
[0091] In summary, the procedures for cell capturing involve placing a transfer surface (e.g., tray) (508a-c) having a number of cell capturing elements (502a-c) thereon. In addition, the cell capturing device (600) is a 3-dimensional closed surface when the top portion (604) is engaged. In some aspects, the inlet port (606), the outlet port (607), and the vacuum port (610) include locks / plugs / stoppers or other structures that may function to completely close the system.
[0092] The fluid provided through the inlet port (606) may include an aqueous solution comprising necessary cell nutrients maintained at physiological viscosity and temperature that may be used to transport the cells into the cell transfer component (600) (e.g., by providing a flow to cause the cells to pass over the cell transfer component (600)). Alternatively, or in addition, the wells within the assay may individually provide nutrients and therefore the nutrients may not be present in the aqueous solution introduced into the cell transfer component (600). Upon initiating an aqueous flow comprising a heterogeneous population of cells into the cell transfer component (600) and above the transfer surface (508a-c), a pressure (less than about 1 atmospheres) is applied below through hole(s) (506a-c) of cell capturing element (502a- c). In some embodiments, there are a number of vacuum ports (610) located at selected intervals to ensure that the overall pressure is substantially uniform (+ / - 20%) at different locations with the transfer surface (508a-c). In some embodiments, a differential flow is established in the bottom portion (602) using one or more inlet ports (606) and outlet ports (607) in the bottom portion (602), wherein the differential flow in the bottom portion (602) relative to the fluid flow in the top portion (604) generates the required vacuum force through the cell capturing element (502a-c) holes / adhesion sites (506a-c). The fluid flow in the top portion (604) is continued until the flow rate and pressure generated indicate that substantially all of the cell capturing elements contain cells, and / or until it is visually confirmed that substantially all of the cell capturing elements contain cells and / or substantially all cells in the top portion are adhered to a cell capturing element (502a-c).
[0093] In some embodiments, the top portion (604) of the cell transfer component (600) is removable from the bottom portion (602). As noted above, the side walls (614) of the bottom portion (602) may extend above the tray (508a-c) such that the removal of the top portion (604) of the cell transfer component (600) will not expose the cells to the atmosphere. To remove the top portion (604), the fluid level is reduced by draining (with or without a vacuum) to the bottom of the inlet port(s) (606) / outlet port(s) (607) which lie above the tray (508a-c). Once the fluid level is lower than the inlet port(s) (606) / outlet port(s) (607) above the cell, further lowering of the fluid level can be done with the vacuum provided that the fluid level remainsAttorney Docket No.009775.00019\WO above the transfer surface (508a-c).
[0094] In some embodiments, the top portion (604) of the cell transfer component (600) is or includes the assay device, which is configured to have the assay wells (e.g., 200a-b, not shown in FIG. 6 for clarity of illustration of the elements in FIG. 6) aligned with, and opening towards, the cell capturing elements (502a-c). In such a case, merely inverting the cell transfer component (600) will result in a transfer of the cells from the cell transfer component (600) into the assay device while being maintained, substantially at all times, in an aqueous environment. As such, inverting the transfer component (600) and allowing the cells to release from the capturing elements and fall by gravity into the corresponding (aligned) assay well of the multi- well assay device. This transfer, relying on gravity and occurring in a consistent aqueous environment, is gentle and minimizes unintended perturbations to the cell (e.g., damage, strain, shearing, variation in environment, etc.)
[0095] In some embodiments, when the top portion (604) of the cell transfer component (600) includes the assay device, the top portion (604) may slide downward from a first lock position above the inlet port (606) to a second lock position below the inlet port (606), to minimize the distance between the cell capturing elements (502a-c) and the assay wells. In some embodiments, the distance between the assay wells in the top portion (604) of the cell transfer component (600) and the tray (508a-c), in the first locked position is, preferably, no more than about 50 microns and, more preferably, no more than about 25 microns. Likewise, when the top portion (604) of the cell transfer component (600) is slidably engaged to a closer position, the distance between the assay wells and\or the tray (508a-c) may be less than that prior to being slidably engaged. A space formed by the top portion (604) and the assay wells may be filled with liquid, such as cell media, such that no air remains. Upon inverting (flipping) the locked device, the cells may be released by gravity into their respective wells of the assay device. If necessary, the vacuum line can be reversed so that a small positive pressure may be created above the cell transfer elements (502a-c) to facilitate the deposit of the cells into the respective assay wells.
[0096] In the case that the cell transfer elements (502b-c) are scalloped and / or recessed regions (510b-c) without hole(s) / adhesion sites (see, e.g., FIG. 8), the transfer device does not comprise a bottom portion as described above, but constitutes a transfer surface (508b-c) with scalloped and / or recessed regions (510b-c) located to face and align with centers of corresponding wells of a multi-well assay device comprising and / or attached to the cell transfer element.
[0097] FIG. 7 shows an example implementation of the transfer component 600 as part of a multi-well assay device. In FIG. 7, the cell capturing elements (502a-c) are through holes. TheAttorney Docket No.009775.00019\WO lid and / or cover (612)comprises a multi-well surface comprising assay wells (200a-b). The cell capturing elements (502a-c) are positioned to match a pitch of the assay wells (200a-b) (i.e., to align on a one-to-one basis). The inlet ports 606 and outlet ports 607 are used to set up a flow of cells through the top portion (604) and a differential flow through the bottom portion (602) to establish a vacuum / negative pressure through the through holes to capture the cells. The device is inverted and flows stopped to allow the cells to fall into corresponding wells.
[0098] FIG. 8 shows an example implementation of a transfer component 600 as part of a multi-well assay device. In FIG. 7, the cell capturing elements (502b-c) are scalloped and / or recessed regions (510b-c), as disclosed herein. The lid and / or cover comprises a multi-well surface comprising assay wells (200a-b). The cell capturing elements (502a-c) are positioned to match the pitch of the assay wells (200a-b) (i.e., to align with on a one-to-one basis). The inlet port 606 and outlet port 607 are used to set up a flow of cells through the top portion (604) so that the cells pass slowly over the scalloped and / or recessed regions (510b-c). The device is inverted, allowing the cells to fall into corresponding wells.
[0099] FIG. 9 shows an example multi-well assay device comprising a transfer device, as described herein. The transfer component comprises a transfer surface configured as a through hole array. The multi-well device is configured with ports to and from a flow cell above the through hole array and ports to and from a flow cell below the flow cell array, configured to generate a differential flow across the top and bottom of the through-hole array. A difference in flow rate set up a pressure differential that traps cells as illustrated in the time-lapse images below. A flow over the transfer surface (i.e., between the transfer surface and assay wells) occurred at a rate of 5 microliters per minute, while the flow below the transfer surface occurred at a rate of 10 microliters per minute, setting up a pressure differential drawing cells and media across the cell capturing elements. Arrows indicate the direction of the flow of cells. The flow above the through hole array caused cells to flow over the surface, and become trapped by individual through holes over time, as shown in the time-lapse pictures of the through hole array with cells passing over, where t1, t2, and t3are time points that are each 5 seconds apart. This example illustrates an implementation of the top portion of FIG. 7, before inverting the device and allowing cells to fall into the individual assay wells.
[0100] FIG. 10 shows a brightfield image of cells after being transferred from the through holes (e.g., as demonstrated in FIG. 9, to assay wells (e.g., as in the bottom portion of FIG. 7, after inverting the device). The majority of wells have single cells, illustrating a low error rate of multiple cells per well or no cells per well. In an example implementation, the device of FIGS. 9-10 included 120,000 assay wells and corresponding through holes. After applying a flow with T-cells to the device and capturing with the through holes, and then inverting as inAttorney Docket No.009775.00019\WO FIG. 7, 81% of assay wells (97,200 wells) had a single cell, 10% of wells were empty, and 9% of cells had multiple cells. These results were achieved after a total time of 10 minutes from the introduction of the T-cells to the transfer surface as in FIG. 9. System for identifying a cell from a population
[0101] As above, this disclosure provides for a system that allows the identification of a specific cell from a population of heterogeneous cells that are being tested in an assay well. In some embodiments, the disclosed system also encompasses the ability to identify other features used in the assay such as the technician doing the assay, the conditions being used in the assay, the date and optionally the time that the assay was conducted, the synthetic steps used to generate a test compound, and the like. In some aspects, the system described herein may include a cell transfer component as disclosed herein, e.g., that transfers a single cell to the assay device via a vacuum force created within the cell capturing element. Further, as previously described, the cell capturing element may include a number and / or size of points / area of contact configured to stably adhere the single cell to the capturing element. Alternatively, or in addition, the cell capturing element may include a multiplicity of points of contact with the vacuum force and / or an area of contact with the vacuum force such that the amount of vacuum force required to stably adhere to the single cell decreases as the points / area of contact increases. For example, the points of contact may be a number of holes / adhesion sites having a predetermined diameter. The predetermined diameter may be based on a number of the holes / adhesion sites as described herein.
[0102] The system so disclosed comprises a high through-put assay device (greater than 3,000 assay wells and, preferably, greater than 30,000 wells, and, more preferably, greater than 300,000 wells), an EMC, and a transfer component, each of which is described above.
[0103] To clarify the use of and to hereby provide notice to the public, the phrases "at least one of , , … and <N>" or "at least one of , , … or <N>" or "at least one of , , … <N>, or combinations thereof" or ", , … and / or <N>" are defined by the Applicant in the broadest sense, superseding any other implied definitions hereinbefore or hereinafter unless expressly asserted by the Applicant to the contrary, to mean one or more elements selected from the group comprising A, B, … and N. In other words, the phrases mean any combination of one or more of the elements A, B, … or N including any one element alone or the one element in combination with one or more of the other elements which may also include, in combination, additional elements not listed.
[0104] Unless otherwise indicated or the context suggests otherwise, as used herein, "a" or "an" means "at least one" or "one or more."
[0105] While various embodiments have been described, it will be apparent to those ofAttorney Docket No.009775.00019\WO ordinary skill in the art that many more embodiments and implementations are possible. Accordingly, the embodiments described herein are examples, not the only possible embodiments and implementations.
[0106] In addition to the features mentioned in each of the independent aspects enumerated above, some examples may show, alone or in combination, the optional features mentioned in the dependent aspects and / or as disclosed in the description above and shown in the figures. Embodiments
[0107] Embodiment 1. A transfer component configured to transfer a single cell to a single well of a multi-well assay device.
[0108] Embodiment 2. The transfer component of embodiment 1, comprising a floor with side walls extending upward to form a volume.
[0109] Embodiment 3. The transfer component of any one of embodiments 1-2, comprising a tray positioned to separate the volume into a bottom portion comprising the floor and a top portion.
[0110] Embodiment 4. The transfer component of any one of embodiments 1-3, wherein the tray comprises a plurality of cell capturing elements on a surface away from the floor.
[0111] Embodiment 5. The transfer component of any one of embodiments 1-4, wherein a first inlet port is formed in a first side wall between the tray and the floor,
[0112] Embodiment 6. The transfer component of any one of embodiments 1-5, wherein a first outlet port is formed in a second side wall between the tray and the floor,
[0113] Embodiment 7. The transfer component of any one of embodiments 1-6, wherein each cell capturing element of the plurality of cell capturing elements comprises one or more through holes between the bottom portion and the top portion, such that a flow established via the first inlet port and the first outlet port causes negative pressure through the one or more through holes in a direction from the top portion to the bottom portion, and
[0114] Embodiment 8. The transfer component of any one of embodiments 1-7, wherein the plurality of cell capturing elements are positioned on the tray to be configured to each align with and face a single corresponding assay well of the multi-well assay device when the multi- well assay device is engaged with the transfer component.
[0115] Embodiment 9. The transfer component of any one of embodiments 1-8, wherein, a second inlet port is formed in the first side wall above the tray; a second outlet port is formed in the second side wall above the tray, and the second inlet port and the second outlet port are configured to establish a flow through the top portion of the transfer component that is less than the flow established via the first inlet port and the first outlet port.Attorney Docket No.009775.00019\WO
[0116] Embodiment 10. The transfer component of any one of embodiments 1-9, wherein at least one cell capturing element of the plurality of cell capturing elements comprises at least four through holes.
[0117] Embodiment 11. The transfer component of any one of embodiments 1-10, wherein at least one cell capturing element of the plurality of cell capturing elements is configured to facilitate release of the cell into the single corresponding assay well by applying a positive pressure to a captured cell.
[0118] Embodiment 12. The transfer component of any one of embodiments 1-11, wherein a cell capturing element of the plurality of cell capturing elements is configured to generate a vacuum force on a single cell to transfer the single cell to the assay device.
[0119] Embodiment 13. The transfer component of any one of embodiments 1-12, wherein the one or more through holes have one or more diameters that result in a total area of contact for a cell with the one or more through holes, wherein the total area of contact for the cell and the negative pressure result in a vacuum force sufficient to stably adhere a single cell.
[0120] Embodiment 14. The transfer component of any one of embodiments 1-3, wherein the transfer device is integral to the multi-well assay device.
[0121] Embodiment 15. The transfer component of any one of embodiments 1-2, comprising a plurality of cell capturing elements on a surface of the floor facing into the volume.
[0122] Embodiment 16. The transfer component of embodiment 15, wherein an inlet port is formed in a first side wall above the floor,
[0123] Embodiment 17. The transfer component of any one of embodiments 15-16, wherein an outlet port is formed in a second side wall above the floor,
[0124] Embodiment 18. The transfer component of any one of embodiments 15-17, wherein the inlet port and the outlet port are configured to generate a flow of a population of cells, comprising the single cell, over the plurality of cell capturing elements,
[0125] Embodiment 19. The transfer component of any one of embodiments 15-18, wherein each of the plurality of cell capturing elements comprises at well having a diameter within 0.5-2x an average diameter of the population of cells and a depth within 0.5-2x an average height of the population of cells, and
[0126] Embodiment 20. The transfer component of any one of embodiments 15-19, wherein the plurality of cell capturing elements are positioned to each align with and face a single corresponding assay well of the multi-well assay device.
[0127] Embodiment 21. The transfer component of any one of embodiments 15-20, wherein at least one cell capturing element of the plurality of cell capturing elements isAttorney Docket No.009775.00019\WO configured to facilitate release of the cell into the single corresponding assay well by applying a positive pressure to a captured cell.
[0128] Embodiment 22. A system for conducting an assay on a heterogenous population of cells, the system comprising: an assay device comprising a multiplicity of assay wells, wherein an assay well of the multiplicity of assay wells comprises an encoded micro-component configured to identify at least one characteristic of contents of the assay well and / or at least one aspect of an assay conducted in the assay well; and a cell transfer component configured to transfer a single cell originating from the heterogenous population of cells to the assay well, the cell transfer component comprising at least one cell capturing element aligned with and facing the assay well.
[0129] Embodiment 23. The system of embodiment 22, wherein the transfer component is the transfer component of any one of embodiments 1-21.
[0130] Embodiment 24. The system of any one of embodiments 22-23, wherein the cell capturing element comprises at least four adhesion sites and wherein the at least four adhesion sites are configured to capture the single cell by applying negative pressure to the single cell.
[0131] Embodiment 25. The system of any one of embodiments 22-24, wherein the at least four adhesion sites are configured to facilitate release of the single cell into the assay well by applying a positive pressure.
[0132] Embodiment 26. The system of any one of embodiments 22-25, wherein the encoded micro-component is configured to identify one or more of: an identity of a technician conducting the assay, a temperature, pH, or atmospheric pressure in the assay well during the assay; a date and / or time the assay was conducted; one or more synthetic steps used to generate a test compound in the assay well; or one or more reaction products of the assay in the assay well.
[0133] Embodiment 27. The system of any one of embodiments 22-26, wherein the assay well comprises a surface that forms a recess configured to accommodate the encoded micro- component.
[0134] Embodiment 28. The system of any one of embodiments 22-27, wherein the recess is configured to exclude the single cell.
[0135] Embodiment 29. A method for performing an assay on a heterogeneous population of cells, the method comprising capturing each cell, of the heterogeneous population of cells, via negative pressure applied via a one or more adhesion sites of a respective cell capturing element of a plurality of cell capturing elements.
[0136] Embodiment 30. The method of embodiment 29, further comprising aligning the plurality of cell capturing elements with a plurality of assay wells.Attorney Docket No.009775.00019\WO
[0137] Embodiment 31. The method of any one of embodiments 29-30, wherein each assay well comprising an encoded micro-component configured to identify at least one characteristic of contents of the assay well and / or at least one aspect of the assay conducted in the assay well.
[0138] Embodiment 32. The method of any one of embodiments 29-31, comprising releasing the captured cells from respective cell capturing elements, of the plurality of cell capturing elements, into a respective assay well, of the plurality of assay wells, aligned with the respective cell capturing element, such that a majority of the released cells each become is a single cell in a respective assay well; and
[0139] Embodiment 33. The method of any one of embodiments 29-32, comprising applying one or more perturbations to the released cells in their respective assay wells.
[0140] Embodiment 34. The method of any one of embodiments 29-33, wherein each encoded micro-component comprises a respective detectable code configured to identify the at least one characteristic and / or the at least one aspect of the assay conducted in an assay well comprising the encoded micro-component.
[0141] Embodiment 35. The method of any one of embodiments 29-34, comprising imaging the assay well comprising the encoded micro-component and a single cell, of the released cells, to detect the detectable code and one or more features of the single cell.
[0142] Embodiment 36. The method of embodiment 35, comprising corresponding a change, after application of a perturbation of the one or more perturbations, in the one or more features to the detectable code.
[0143] Embodiment 37. The method of any one of embodiments 29-36, wherein the encoded micro-component is one or more of a quantum dot or a dye.
[0144] Embodiment 38. An assay device comprising a plurality of assay wells such that each assay well accommodates at least one cell, wherein the cell is from a population of heterogenous cells and wherein each assay well includes at least one encoded micro-component (EMC).
[0145] Embodiment 39. The assay device of embodiment 38, wherein the EMC comprises a detectible code on at least one surface of the EMC.
[0146] Embodiment 40. The assay device of any one of embodiments 38-39, wherein the detectible code comprises an identifiable pattern of at least one label and / or image.
[0147] Embodiment 41. The assay device of any one of embodiments 38-40, wherein the detectible code on the EMC is unique to the assay well.
[0148] Embodiment 42. The assay device of any one of embodiments 38-41, the detectible code links the identity of the cell to an assay well from which the cell originated.Attorney Docket No.009775.00019\WO
[0149] Embodiment 43. The assay device of any one of embodiments 38-42, wherein the surface of the EMC comprises an orientation marker.
[0150] Embodiment 44. The assay device of any one of embodiments 38-43, wherein the orientation marker is a label and / or image configured to be used to orient reading of the detectable code.
[0151] Embodiment 45. The assay device of any one of embodiments 38-44, wherein the detectable code on the EMC is visually detectable.
[0152] Embodiment 46. The assay device of any one of embodiments 38-45, wherein the detectable code on the EMC is detectable by physical means.
[0153] Embodiment 47. The assay device of any one of embodiments 38-46, wherein the physical means includes inducing and measuring fluorescence generated on the EMC.
[0154] Embodiment 48. The assay device of any one of embodiments 38-47, wherein the detectable code on the EMC is detectable by chemical means.
[0155] Embodiment 49. The assay device of any one of embodiments 38-48, wherein at least one label included on the EMC is a detectable dot or color.
[0156] Embodiment 50. The assay device of any one of embodiments 38-49, wherein each detectable dot is detected by different detection means.
[0157] Embodiment 51. The assay device of any one of embodiments 38-50, wherein the plurality of assay wells includes microwells, nanowells, and / or picowells.
[0158] Embodiment 52. The assay device of any one of embodiments 38-51, wherein the EMC is embedded in a bead.
[0159] Embodiment 53. The assay device of any one of embodiments 38-52, wherein the bead is translucent or at least one surface of the EMC is exposed from the surface of the bead, wherein the exposed surface comprises the detectible code.
[0160] Embodiment 54. A system for conducting an assay starting with a population of cells, the system comprising a cell transfer device configured to transfer a single cell originating from a population of cells to a single assay well of an assay device, the cell transfer device including at least one cell capturing element; and the assay device comprising the assay well.
[0161] Embodiment 55. The system of embodiment 54, wherein the assay device comprises a multiplicity of assay wells, wherein at least one assay well in the assay device comprises the single cell transferred via the cell transfer device.
[0162] Embodiment 56. The system of any one of embodiments 54-55, wherein at least one assay well in the assay device comprises: an encoded micro component (EMC) comprising a detectable code configured to identify at least one characteristic of contents of the assay well and / or at least one aspect of the assay conducted in the well.Attorney Docket No.009775.00019\WO
[0163] Embodiment 57. The system of any one of embodiments 54-56, wherein the cell transfer device comprises the transfer component of any one of embodiments 1-21.
[0164] Embodiment 58. The system of any one of embodiments 54-57, wherein the assay device comprises the assay device of any one of or embodiments38-52.
[0165] Embodiment 59. The system of any one of embodiments 54-58, wherein the cell transfer device transfers the single cell to the assay device via a vacuum force created within the cell capturing element.
[0166] Embodiment 60. The system of any one of embodiments 54-59, wherein the cell capturing element includes at least four points of contact configured to stably adhere a single cell to the capturing element.
[0167] Embodiment 61. The system of any one of embodiments 54-60, wherein the cell capturing element includes a multiplicity of points of contact such that a vacuum force used to stably adhere the single cell decreases as the points of contact increase.
[0168] Embodiment 62. The system of any one of embodiments 54-61, wherein the points of contact are holes having a predetermined diameter.
[0169] Embodiment 63. The system of any one of embodiments 54-62, wherein at least one surface of the EMC includes an orientation marker configured to orient reading of the detectable code.
[0170] Embodiment 64. The system of any one of embodiments 54-63, wherein the orientation marker is a unique label and / or image that is used to orient the reading of the detectable code.
[0171] Embodiment 65. The system of any one of embodiments 54-64, wherein the detectable code on the EMC is visually detectable.
[0172] Embodiment 66. The system of any one of embodiments 54-65, wherein the detectable code on the EMC is detectable by physical means.
[0173] Embodiment 67. The system of any one of embodiments 54-66, wherein the physical means include inducing and measuring fluorescence generated on the EMC.
[0174] Embodiment 68. The system of any one of embodiments 54-67, wherein a detectable code on the EMC is detectable by chemical means.
[0175] Embodiment 69. The system of any one of embodiments 54-68, wherein at least one label included on the EMC is a detectable dot or color.
[0176] Embodiment 70. The system of any one of embodiments 54-69, wherein each detectable dot is detectable by a combination of different detection means.
[0177] Embodiment 71. The system of any one of embodiments 54-70, wherein the multiplicity of assay wells includes microwells, nanowells, and / or picowells.Attorney Docket No.009775.00019\WO
[0178] Embodiment 72. The system of any one of embodiments 54-71, wherein the EMC is embedded into a bead, and at least one surface of the EMC is visible from a surface of the bead.
[0179] Embodiment 73. The system of any one of embodiments 54-72, wherein the at least one surface of the EMC exposed on the surface of the bead includes the detectible code.
Claims
Attorney Docket No.009775.00019\WO WHAT IS CLAIMED IS:
1. A transfer component configured to transfer a single cell to a single well of a multi-well assay device, the transfer component comprising: a floor with side walls extending upward to form a volume; and a tray positioned to separate the volume into a bottom portion comprising the floor and a top portion, wherein the tray comprises a plurality of cell capturing elements on a surface away from the floor; wherein a first inlet port is formed in a first side wall between the tray and the floor, wherein a first outlet port is formed in a second side wall between the tray and the floor, wherein each cell capturing element of the plurality of cell capturing elements comprises one or more through holes between the bottom portion and the top portion, such that a flow established via the first inlet port and the first outlet port causes negative pressure through the one or more through holes in a direction from the top portion to the bottom portion, and wherein the plurality of cell capturing elements are positioned on the tray to be configured to each align with and face a single corresponding assay well of the multi-well assay device when the multi-well assay device is engaged with the transfer component.
2. The transfer component of claim 1, wherein: a second inlet port is formed in the first side wall above the tray; a second outlet port is formed in the second side wall above the tray, and the second inlet port and the second outlet port are configured to establish a flow through the top portion of the transfer component that is less than the flow established via the first inlet port and the first outlet port.
3. The transfer component of claim 1, wherein at least one cell capturing element of the plurality of cell capturing elements comprises at least four through holes.
4. The transfer component of claim 1, wherein at least one cell capturing element of the plurality of cell capturing elements is configured to facilitate release of the cell into the single corresponding assay well by applying a positive pressure to a captured cell.Attorney Docket No.009775.00019\WO 5. The transfer component of claim 1, wherein a cell capturing element of the plurality of cell capturing elements is configured to generate a vacuum force on a single cell to transfer the single cell to the assay device.
6. The transfer component of claim 1, wherein the one or more through holes have one or more diameters that result in a total area of contact for a cell with the one or more through holes, wherein the total area of contact for the cell and the negative pressure result in a vacuum force sufficient to stably adhere a single cell.
7. The transfer component of claim 1, wherein the transfer device is integral to the multi-well assay device.
8. A transfer component configured to transfer a single cell to a single assay well of a multi-well assay device, the transfer component comprising: a floor with side walls extending upward to form a volume; and a plurality of cell capturing elements on a surface of the floor facing into the volume; wherein an inlet port is formed in a first side wall above the floor, wherein an outlet port is formed in a second side wall above the floor, wherein the inlet port and the outlet port are configured to generate a flow of a population of cells, comprising the single cell, over the plurality of cell capturing elements, wherein each of the plurality of cell capturing elements comprises at well having a diameter within 0.5-2x an average diameter of the population of cells and a depth within 0.5-2x an average height of the population of cells, and wherein the plurality of cell capturing elements are positioned to each align with and face a single corresponding assay well of the multi-well assay device.
9. A system for conducting an assay on a heterogenous population of cells, the system comprising: a) an assay device comprising a multiplicity of assay wells, wherein an assay well of the multiplicity of assay wells comprises an encoded micro-component configured to identifyAttorney Docket No.009775.00019\WO at least one characteristic of contents of the assay well and / or at least one aspect of an assay conducted in the assay well; and b) a cell transfer component configured to transfer a single cell originating from the heterogenous population of cells to the assay well, the cell transfer component comprising at least one cell capturing element aligned with and facing the assay well.
10. The system of claim 9, wherein the cell capturing element comprises at least four adhesion sites and wherein the at least four adhesion sites are configured to capture the single cell by applying negative pressure to the single cell.
11. The system of claim 10, wherein the at least four adhesion sites are configured to facilitate release of the single cell into the assay well by applying a positive pressure.
12. The system of claim 9, wherein the encoded micro-component is configured to identify one or more of: an identity of a technician conducting the assay, a temperature, pH, or atmospheric pressure in the assay well during the assay; a date and / or time the assay was conducted; one or more synthetic steps used to generate a test compound in the assay well; or one or more reaction products of the assay in the assay well.
13. The system of claim 9, wherein the assay well comprises a surface that forms a recess configured to accommodate the encoded micro-component.
14. The system of claim 13, wherein the recess is configured to exclude the single cell.
15. A method for performing an assay on a heterogeneous population of cells, the method comprising: capturing each cell, of the heterogeneous population of cells, via negative pressure applied via a one or more adhesion sites of a respective cell capturing element of a plurality of cell capturing elements;Attorney Docket No.009775.00019\WO aligning the plurality of cell capturing elements with a plurality of assay wells, each assay well comprising an encoded micro-component configured to identify at least one characteristic of contents of the assay well and / or at least one aspect of the assay conducted in the assay well; releasing the captured cells from respective cell capturing elements, of the plurality of cell capturing elements, into a respective assay well, of the plurality of assay wells, aligned with the respective cell capturing element, such that a majority of the released cells each become is a single cell in a respective assay well; and applying one or more perturbations to the released cells in their respective assay wells.
16. The method of claim 15, wherein each encoded micro-component comprises a respective detectable code configured to identify the at least one characteristic and / or the at least one aspect of the assay conducted in an assay well comprising the encoded micro- component.
17. The method of claim 16, further comprising imaging the assay well comprising the encoded micro-component and a single cell, of the released cells, to detect the detectable code and one or more features of the single cell; and corresponding a change, after application of a perturbation of the one or more perturbations, in the one or more features to the detectable code.
18. The method of claim 17, wherein the encoded micro-component is one or more of a quantum dot or a dye.
19. An assay device comprising a plurality of assay wells such that each assay well accommodates at least one cell, wherein the cell is from a population of heterogenous cells and wherein each assay well includes at least one encoded micro-component (EMC), the EMC comprising: a detectible code on at least one surface of the EMC, the detectible code comprising an identifiable pattern of at least one label and / or image, wherein the detectible code on the EMC is unique to the assay well and the detectible code links the identity of the cell to an assay well from which the cell originated.Attorney Docket No.009775.00019\WO 20. The assay device of claim 19, wherein the surface of the EMC comprises an orientation marker.
21. The assay device of claim 20, wherein the orientation marker is a label and / or image configured to be used to orient reading of the detectable code.
22. The assay device of claim 19, wherein the detectable code on the EMC is visually detectable.
23. The assay device of claim 19, wherein the detectable code on the EMC is detectable by physical means.
24. The assay device of claim 23, wherein the physical means includes inducing and measuring fluorescence generated on the EMC.
25. The assay device of claim 19, wherein the detectable code on the EMC is detectable by chemical means.
26. The assay device of claim 19, wherein at least one label included on the EMC is a detectable dot or color.
27. The assay device of claim 26, wherein each detectable dot is detected by different detection means.
28. The assay device of claim 19, wherein the plurality of assay wells includes microwells, nanowells, and / or picowells.
29. The assay device of claim 19, wherein the EMC is embedded in a bead.
30. The assay device of claim 29, wherein the bead is translucent or at least one surface of the EMC is exposed from the surface of the bead, wherein the exposed surfaceAttorney Docket No.009775.00019\WO comprises the detectible code.
31. A system for conducting an assay starting with a heterogeneous population of cells, the system comprising: a) a cell transfer device configured to transfer a single cell originating from a heterogenous population of cells to a single assay well, the cell transfer device including at least one cell capturing element; and b) an assay device comprising a multiplicity of assay wells, wherein at least one assay well in the assay device comprises the single cell transferred via the cell transfer device, and wherein at least one well in the assay device comprises: an encoded micro component (EMC) comprising a detectable code configured to identify at least one characteristic of contents of the assay well and / or at least one aspect of the assay conducted in the well.
32. The system of claim 31, wherein the cell transfer device transfers the single cell to the assay device via a vacuum force created within the cell capturing element.
33. The system of claim 32, wherein the cell capturing element includes at least four points of contact configured to stably adhere a single cell to the capturing element.
34. The system of claim 31, wherein the cell capturing element includes a multiplicity of points of contact such that a vacuum force used to stably adhere the single cell decreases as the points of contact increase.
35. The system of claim 34, wherein the points of contact are holes having a predetermined diameter.
36. The system of claim 31, wherein at least one surface of the EMC includes an orientation marker configured to orient reading of the detectable code.
37. The system of claim 36, wherein the orientation marker is a unique label and / or image that is used to orient the reading of the detectable code.Attorney Docket No.009775.00019\WO 38. The system of claim 31, wherein the detectable code on the EMC is visually detectable.
39. The system of claim 31, wherein the detectable code on the EMC is detectable by physical means.
40. The system of claim 39, wherein the physical means include inducing and measuring fluorescence generated on the EMC.
41. The system of claim 31, wherein a detectable code on the EMC is detectable by chemical means.
42. The system of claim 31, wherein at least one label included on the EMC is a detectable dot or color.
43. The system of claim 42, wherein each detectable dot is detectable by a combination of different detection means.
44. The system of claim 31, wherein the multiplicity of assay wells includes microwells, nanowells, and / or picowells.
45. The system of claim 31, wherein the EMC is embedded into a bead, and at least one surface of the EMC is visible from a surface of the bead.
46. The system of claim 45, wherein the at least one surface of the EMC exposed on the surface of the bead includes the detectible code.
Citation Information
Patent Citations
Method and device for taking measurements of cells which are contained in a liquid environment
US20030080314A1
Single cell capture with polymer capture films
US20160033378A1
Mesh for cell layer preparation
US20220250074A1
Transfer dispensers for assay devices with bead size exclusion
WO2022261135A1
